Want to see JP:7459 full AI Analyst Report?
Medipal Holdings (7459) Price & Analysis
7459 Stock Chart & Stats
- Day’s Range
- JPY 3,371.00 - JPY 3,441.00
- 52-Week Range
- JPY 2,456.50 - JPY 3,449.00
- Previous Close
- JPY 3,374.00
- Volume
- 650.70K
- Average Volume (3M)
- 460.02K
- Market Cap
- JPY 624.24B
- Enterprise Value
- JPY 432.01B
- Total Cash (Recent Filing)
- JPY 289.92B
- Total Debt (Recent Filing)
- JPY 43.23B
- Price to Earnings (P/E)
- 15.1
- Beta
- 0.36
- Next Earnings
- Feb 03, 2027
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Mar 30, 2027
- Dividend Yield
- 2.27%
Bulls Say, Bears Say
Bulls Say
Steady Revenue Growth
Multi-year revenue growth indicates resilient demand across the distribution business and supports the durability of its healthcare and consumer-goods customer base. Continued top-line expansion can reinforce scale advantages, sustain network relevance, and provide a foundation for dependable operating performance.
Very Conservative Balance Sheet
Minimal leverage materially reduces financial risk and leaves the company less exposed to refinancing pressure or rising interest costs. The conservative balance sheet also preserves flexibility to maintain operations, support distribution capabilities, and pursue growth while protecting long-term stability.
Generally Positive Cash Generation
Recurring positive free cash flow demonstrates that the distribution model can convert operations into internally generated funds across multiple periods. This supports ongoing investment, shareholder distributions, and balance-sheet resilience, even though the timing of cash generation is not completely consistent.
Bears Say
Structurally Thin Margins
Very thin profitability leaves limited room to absorb operating pressure, cost increases, or execution setbacks before earnings are affected. The low-margin structure also means that sustained revenue growth may translate into only modest absolute profit expansion unless efficiency or operating leverage improves.
Variable Cash Flow
Uneven cash conversion makes the company’s internally funded resources less predictable from year to year. The stated influence of working-capital swings can complicate investment and capital-allocation planning, requiring continued monitoring even when reported earnings and free cash flow are generally positive.
Operating Profit Volatility
A reduction in EBIT while revenue increased suggests that incremental sales are not consistently producing stronger operating returns. This limits confidence in near-term margin expansion and indicates that earnings remain sensitive to the economics of the scale-driven distribution model.
Medipal Holdings News
7459 FAQ
What was Medipal Holdings’s price range in the past 12 months?
What is Medipal Holdings’s market cap?
When is Medipal Holdings’s upcoming earnings report date?
How were Medipal Holdings’s earnings last quarter?
Is Medipal Holdings overvalued?
Does Medipal Holdings pay dividends?
What is Medipal Holdings’s EPS estimate?
How many shares outstanding does Medipal Holdings have?
What happened to Medipal Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Medipal Holdings?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Medipal Holdings
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Shuichi Watanabe
- Employees
- 13,024
- Website
- www.medipal.co.jp
- Address
- 3-1-1 Kyobashi, Tokyo, TY, 104-8461, JP
Medipal Holdings (7459) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 2 | 6 |
| Technical Analysis | 2 | 2 | 6 |
| Moving Averages | 12 | 0 | 0 |









